barrons.com rank 538 |
Number of domains linking to barrons.com 3 | semantic flow 2.69 |
Number of links to barrons.com 66 | semantic flow 2.69 |
Number of domains linked from barrons.com 2 | semantic flow 0.09 |
Number of links from barrons.com 2 | semantic flow 0.09 |
Pages with highest topical PageRank pointing to domain.
Relevant domains with most links to selected domain.
domain | |||
---|---|---|---|
http://marketwatch.com/ | 64 | 2.6 | marketwatch.com |
http://xconomy.com/ | 1 | 0.07 | xconomy.com |
http://benzinga.com/ | 1 | 0.01 | benzinga.com |
Relevant domains with most links from selected domain.
domain | |||
---|---|---|---|
http://barronsmag.com/ | 1 | 0.05 | barronsmag.com |
http://fnlondon.com/ | 1 | 0.05 | fnlondon.com |
Pages from domain with most relevant inbound links.
url | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
https://www.barrons.com/articles/biotech-ready-to-bust-out-1517020754 | 1 | 0.15 | 0.94 | 0.07 | 0.95 | yes | 62 | 9 | 2 | 2 | 1 | 1 | |
http://online.barrons.com/article/SB51168749624217223370504583079144187984164.html?mod=BOL | 1 | 0.15 | 0.92 | 0.06 | -1 | - | -1 | -1 | -1 | -1 | 1 | 1 | |
https://www.barrons.com/articles/gilead-way-oversold-as-investors-flee-biotech-1455231930? | 1 | 0.15 | 0.77 | 0.06 | 0.95 | yes | 62 | 9 | 2 | 2 | 1 | 1 | |
http://online.barrons.com/article/SB50581646784988784368704581593262836071194.html?mod=BOL | 1 | 0.15 | 0.88 | 0.06 | -1 | - | -1 | -1 | -1 | -1 | 1 | 1 | |
http://www.barrons.com/mktlab | 1 | 0.16 | 0.83 | 0.05 | -1 | no | -1 | -1 | -1 | -1 | 0 | 0 | |
http://www.barrons.com/data | 1 | 0.16 | 0.62 | 0.04 | -1 | - | -1 | -1 | -1 | -1 | 0 | 0 | |
https://www.barrons.com/contact | 1 | 0.16 | 0.54 | 0.03 | -1 | - | -1 | -1 | -1 | -1 | 0 | 0 | |
https://www.barrons.com/articles/bayer-buys-more-crispr-stock-after-celgene-sells-15174233 | 1 | 0.15 | 0.63 | 0.03 | -1 | - | -1 | -1 | -1 | -1 | 1 | 1 | |
http://www.barrons.com/advisorcenter?mod=BOL_TOPNAV_AC | 1 | 0.16 | 0.42 | 0.03 | -1 | - | -1 | -1 | -1 | -1 | 0 | 0 | |
https://www.barrons.com/advisorcenter?mod=BOL_HAMNAV_AC | 1 | 0.16 | 0.43 | 0.02 | -1 | - | -1 | -1 | -1 | -1 | 0 | 0 |
Pages from domain with most likely on-topic outgoing links.
url | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
http://www.barrons.com/mktlab | 21 | 0.16 | 0.83 | 0.01 | -1 | no | -1 | -1 | -1 | -1 | 0 | 0 | |
https://www.barrons.com/articles/gilead-way-oversold-as-investors-flee-biotech-1455231930? | 9 | 0.15 | 0.77 | 0.35 | 0.95 | yes | 62 | 9 | 2 | 2 | 1 | 1 | |
https://www.barrons.com/articles/small-is-best-for-biotech-etfs-1514002637 | 2 | 0.15 | 0.76 | 0.04 | 1 | yes | 62 | 11 | 2 | 2 | 1 | 1 | |
https://www.barrons.com/sector-focus | 2 | 0.16 | 0.02 | 0 | -1 | no | -1 | -1 | -1 | -1 | 0 | 0 | |
https://www.barrons.com/articles/incyte-a-biotech-acquisition-target-1468489503?mod=BOLFee | 1 | 0.15 | 0.72 | 0.04 | 0.83 | yes | 62 | 8 | 2 | 2 | 1 | 1 | |
https://www.barrons.com/articles/why-biotech-stocks-are-finally-set-to-break-out-148771566 | 1 | 0.15 | 0.78 | 0.04 | 0.96 | yes | 62 | 10 | 2 | 2 | 1 | 1 | |
https://www.barrons.com/articles/smaller-biotech-buyout-targets-after-medivation-147205187 | 1 | 0.15 | 0.19 | 0.01 | -1 | no | -1 | -1 | -1 | -1 | 1 | 1 | |
https://www.barrons.com/articles/cancer-therapy-may-see-major-shift-1458071085?mod=BOLFeed | 1 | 0.15 | 0.02 | 0 | -1 | no | -1 | -1 | -1 | -1 | 1 | 1 |
Similar domains to domain, based on inbound linking patterns from other relevant domains. This is also known in SEO as topical co-citation.